Cera Sanitaryware Ltd

- No explicit mention of new fundraising through debt or equity in the transcript. - The company has a strong cash position with INR 853 crore cash and cash equivalents as of March 2026. - There is discussion about planned capital expenditure (~INR 43-45 crore) and potential greenfield project (~INR 150 crore). - Management stated that future investments will be evaluated based on market conditions and demand traction. - Dividend payout has been emphasized, reflecting respect for cash position. - No direct indication of plans to raise funds via debt or equity in the near term; focus is on utilizing existing cash and prudent financial management.

- FY26 capex was INR 14.5 crore, mainly for routine maintenance and brand/retail strengthening. - FY27 capex budget around INR 43-45 crore, including: - Routine capex of INR 25 crore. - INR 5 crore for faucetware capacity expansion. - INR 15 crore for acquisition of additional office space. - Faucetware capacity being increased from 4.3 lakh to 5 lakh pieces per month with minimal capex of INR 4-5 crore, operational from Q4 FY27. - Greenfield sanitaryware project under evaluation: - Initial land purchased for INR 27 crore. - Projected construction cost around INR 150 crore (up from INR 130 crore due to inflation). - Timing for greenfield construction to be decided based on market demand in coming quarters. - Continued investment in Senator and Polipluz brands focusing on store expansion and marketing (INR 10-12 crore publicity budget planned for FY27).

- Overall revenue growth for FY27 expected at 18-20%. - Sanitaryware segment revenue to grow around 12%, driven by volume growth of 7-8% and price increases of 5-6%. - Faucetware revenue growth to be around 18%, with volume growth of 10-12% and price increase of about 8%. - Retail demand showing strong recovery since Q3 FY26, expected to continue throughout FY27. - Institutional/project business remains stable at ~40% of total sales, with retail at ~60%. - New brands Senator and Polipluz expected to achieve combined revenue of INR 70-80 crore in FY27 (Senator INR 40-45 crore; Polipluz INR 30-35 crore). - Faucetware monthly capacity being expanded from 4.3 lakh to 5 lakh pieces, enhancing growth potential. - Price hikes executed to offset rising input costs, supporting margin maintenance alongside volume growth.

- FY27 revenue growth expected at 18-20%, driven by: - Sanitaryware growth: 12% (7% volume + 5-6% price impact) - Faucetware growth: 18% (10-12% volume + 8% price impact) - Additional contributions from tiles, construction chemicals, Senator and Polipluz brands - Senator and Polipluz combined revenue projected at INR 70-80 crore in FY27 (up from INR 19 crore in FY26) - EBITDA margins expected to sustain around 14-15%, supported by calibrated price revisions and better discount management - Losses from Senator and Polipluz expected to continue in FY27 due to publicity costs, with profitability targeted in subsequent years - FY27 employee expenses expected to stabilize around INR 15.5-16 crore for Senator and Polipluz combined - Capex planned around INR 43-45 crore in FY27, including faucetware expansion and office space acquisition - Overall, company aims steady profit growth with cautious investments and market demand improvements

The transcript on page 13 does not explicitly mention the current or expected order book or pending orders for CERA Sanitaryware Ltd. However, some relevant insights related to demand and order trends are as follows: - Project segment demand has been strong and growing, constituting around 39%-40% of business. - Retail demand has shown a recovery, expected to remain stable at about 60% of total business. - Pricing for projects remains largely stable for one year post-booking. - Price increases have been implemented in retail; project prices will reflect increases with a lag of 5-6 months. - The company is optimistic about 18%-20% overall revenue growth in FY27 driven by strong volume and price growth across sanitaryware and faucets. - The introduction of new brands and improvement in tiles and construction chemicals segments are expected to drive incremental revenue contributing to orderbook strength. No precise quantitative data on order book or pending orders was disclosed.